- Editas Medicine replaced Ernst & Young with PwC as independent auditor for fiscal year ending Dec. 31, 2026, effective April 1, 2026.
- Audit committee dismissed Ernst & Young following a formal review of proposals from other accounting firms.
- Ernst & Young audit reports for 2024 and 2025 carried no adverse opinion, disclaimer, or qualification.
- No accounting or auditing disagreements were reported with Ernst & Young through April 1, 2026.
- Editas reported no prior consultations with PwC on accounting, audit opinions, disagreements, or reportable events through April 1, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Editas Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001650664-26-000030), on April 07, 2026, and is solely responsible for the information contained therein.
Comments